Exploring the epidemiological characteristics of Mpox in the Arab Gulf countries

探讨阿拉伯海湾国家麻痘的流行病学特征

阅读:1

Abstract

In May 2022, Mpox outbreaks emerged in regions where the virus is not traditionally prevalent. This study estimates the mean incubation period, serial interval and the extent of presymptomatic transmission in the Arab Gulf Countries (AGC). The effective reproduction number ([Formula: see text]) is also calculated, as well as the degree of heterogeneity ([Formula: see text]), using the instant-individual heterogeneity transmission model. We analyze data from 41 confirmed cases for which we have complete information, estimating the mean incubation period using gamma, Weibull and lognormal distributions, with respective means of 8.52 (95% CI 7.26-9.98), 8.57 (95% CI 7.28-10.01), and 8.64 (95% CI 7.23-10.26) days. The mean serial interval, based on 31 case pairs, was 7.19 days (95% CI 4.11-12.95), 7.16 days (95% CI 5.80-8.90), and 10.0 days (95% CI 6.30-16.3) for the gamma, Weibull, and lognormal distributions, respectively. The Akaike Information Criterion (AIC) validated the best-fitting models. The serial intervals were shorter than the incubation periods, suggesting that pre-symptomatic transmission occurred in 60% of transmission events. We estimated [Formula: see text] to be 0.95 (95% highest posterior density [HPD]: 0.93-1.35) and [Formula: see text] to be 1.52 (95% HPD: 1.07-5.76), indicating supercritical Mpox transmission in the AGC with limited transmission heterogeneity. Using a Bayesian framework with non-informative priors and a negative binomial distribution, we projected [Formula: see text] to remain between 0.95 and 1.0 from August 2022 to January 2023, underscoring the need for continued efforts to reduce transmissibility. These findings provide valuable information for public health interventions, emphasizing a multifaceted approach to managing Mpox transmission.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。